Abbott (NYSE: ABT) announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic nephropathy (diabetic kidney disease). Study results suggest that atrasentan, used in conjunction with renin-angiotensin system (RAS) inhibitors, may reduce albuminuria (presence of (more…)
Posts Tagged ‘Study’
Abbott Announces Positive Results From Phase 2 Study Of Low Dose Atrasentan For Treatment Of Diabetic Kidney Disease
Tuesday, November 23rd, 2010
Study Finds Correlation Between Childhood Abuse and Diabetes
Thursday, November 11th, 2010New research suggests a correlation between childhood abuse and the development of Type 2 diabetes in female adults, according to an article from Sify.com. Girls that were the victims of moderate and severe abuse also showed a 26%-69% increased risk of getting Type 2 diabetes as adults. The study was published first in the American Journal of Preventative Medicine.
Much of that increased risk comes from a greater weight gain seen generally (more…)
Child’s Diabetes Risk Influenced by Dad’s Weight, Diet: Study
Tuesday, October 26th, 2010New research suggests a link between a child’s risk of Type 2diabetes and the weight and the amount of fat in the father’s diet at the time of conception, according to an article on DLife.
This is the first study to connect a father’s weight and diet to the offspring’s risk of metabolic disease. For the study, researchers fed male rats a diet high in fat to induce obesity and glucose intolerance. The obese rats were then mated (more…)
Bariatric Surgery Pays for Itself in 2-3 Years: Study
Friday, October 15th, 2010New data shows that morbidly obese people with Type 2 diabetes that undergo bariatric surgery fully recover the costs of the surgery in two to three years and experience a significant reduction in diabetes diagnostics claims and diabetes medication claims after the surgery.
The study was conducted by Washington University School of Medicine in St. Louis, Université du Québec à Montréal (UQAM), and Analysis Group, Inc. Many people (more…)
Study Suggests Women And Their Children May Benefit From Metabolic Screening Prior To Conception
Thursday, October 14th, 2010
Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study in the current issue of the American Journal of Epidemiology .
The study suggests that metabolic screening of all women before pregnancy, particularly overweight (more…)